EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Next generation of boron neutron capture therapy (BNCT) agents for cancer treatment

Paolo Coghi, Jinxin Li, Narayan S Hosmane, Yinghuai Zhu iD

Medicinal Research Reviews · 2023-09 · 43 (5) · 1809-1830

DOI: 10.1002/med.21964 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Medicinal Research Reviews, online erschienen am 27.04.2023. Verfasst von Paolo Coghi und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Macau University of Science and Technology, Macau, China. Hauptthemen laut MEDLINE: Boron Neutron Capture Therapy, Neoplasms. Die Arbeit wurde bisher 145-mal zitiert (Crossref) und nennt 111 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Boron neutron capture therapy (BNCT) is one of the most promising treatments among neutron capture therapies due to its long‐term clinical application and unequivocally obtained success during clinical trials. Boron drug and neutron play an equivalent crucial role in BNCT. Nevertheless, current clinically used l ‐boronophenylalanine (BPA) and sodium borocaptate (BSH) suffer from large uptake dose and low blood to tumor selectivity, and that initiated overwhelm screening of next generation of BNCT agents. Various boron agents, such as small molecules and macro/nano‐vehicles, have been explored with better success. In this featured article, different types of agents are rationally analyzed and compared, and the feasible targets are shared to present a perspective view for the future of BNCT in cancer treatment. This review aims at summarizing the current knowledge of a variety of boron compounds, reported recently, for the application of BCNT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Boron Neutron Capture TherapyNeoplasmsHumansBoronBoron Compounds

Stichwörter der Autor:innen

boron clustersboron neutron capture therapyboronated sugarsnanoparticles

Substanzen

BoronBoron Compounds

Autor:innen und Institutionen

  • School of Pharmacy, Macau University of Science and Technology, Macau, China.
  • Department of Chemistry and Biochemistry, Northern Illinois University, DeKalb, Illinois, USA.
  • Sunshine Lake Pharma Co., Ltd., Dongguan, China.

ORCID-Profile: Yinghuai Zhu

Zitieren

APA

Coghi, P., Li, J., Hosmane, N. S., & Zhu, Y. (2023). Next generation of boron neutron capture therapy (BNCT) agents for cancer treatment. Medicinal Research Reviews, 43(5), 1809-1830. https://doi.org/10.1002/med.21964

Vancouver

Coghi P, Li J, Hosmane NS, Zhu Y. Next generation of boron neutron capture therapy (BNCT) agents for cancer treatment. Medicinal Research Reviews. 2023;43(5):1809-1830. doi:10.1002/med.21964

BibTeX
@article{Coghi2023,
  author = {Coghi, Paolo and Li, Jinxin and Hosmane, Narayan S and Zhu, Yinghuai},
  title = {Next generation of boron neutron capture therapy (BNCT) agents for cancer treatment},
  journal = {Medicinal Research Reviews},
  year = {2023},
  volume = {43},
  number = {5},
  pages = {1809--1830},
  doi = {10.1002/med.21964}
}
Kostenlos starten →